Background Approved systemic treatments for malignant pleural mesothelioma (MPM) have
been limited to chemotherapy regimens that have moderate survival benefit with poor …

Malignant pleural mesothelioma (MPM) is characterised by late-stage diagnosis and poor
prognosis. Currently, no screening tool is advocated and diagnosis is based on invasive …

Malignant pleural mesothelioma is an aggressive, incurable cancer that is usually caused by
asbestos exposure several decades before symptoms arise. Despite widespread prohibition …

Importance Some recently proposed frontline therapies for malignant pleural mesothelioma
(MPM) are very costly, yet their impact on quality of life and overall survival of these patients …

Cytology effusions are often the only material available for diagnosing malignant pleural
mesothelioma (MPM). However, the cytomorphological features alone are not always …

Malignant pleural mesothelioma: recent developments : Current Opinion in Oncology Malignant
pleural mesothelioma: recent developments : Current Opinion in Oncology Log in or Register …

Malignant pleural mesothelioma (MPM), an aggressive cancer associated with exposure to
fibrous minerals, can only be diagnosed in the advanced stage because its early symptoms …

Simple Summary CSF1/CSF1R signaling mediates tumor-associated macrophages
recruitment and M2 polarization. M2 TAMs are dominant immune populations infiltrating …

Malignant mesothelioma is a rare malignancy with a poor prognosis whose development is
related to asbestos fiber exposure. An increasing role of genetic predisposition has been …

Background The exact role and type of surgery for malignant pleural mesothelioma (MPM)
remains controversial. This study aimed at analyzing a 20-year single center perioperative …